Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Pharmacological Research|November 24, 2022
Targeting CSF-1R represents an effective strategy in modulating inflammatory diseasesCaigui Xiang, Heng Li, Wei TangCellular Immunology|May 1, 2021
Blockade of TLRs-triggered macrophage activation by caffeic acid exerted protective effects on experimental ulcerative colitisCaigui Xiang, Moting Liu, Qiukai Lu, et al.Acta Pharmaceutica Sinica. B|March 7, 2020
Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactionsHeng Li, Chen Fan, Huimin Lu, et al.Biochemical Pharmacology|February 12, 2022
Interfering with alternatively activated macrophages by CSF-1R inhibition exerts therapeutic capacity on allergic airway inflammationCaigui Xiang, Chen Fan, Qiukai Lu, et al.Journal of Medicinal Chemistry|September 3, 2021
Discovery of Potent Antiallergic Agents Based on an o-Aminopyridinyl Alkynyl ScaffoldZhicheng Xie, Caigui Xiang, Xin Li, et al.Journal of Medicinal Chemistry|January 15, 2020
Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an o-Aminopyridyl Alkynyl Scaffold as Potential Treatment for Inflammatory DisordersZhicheng Xie, Bing Wu, Yingqiang Liu, et al.Journal of Advanced Research|October 4, 2021
Identification of phosphodiesterase-4 as the therapeutic target of arctigenin in alleviating psoriatic skin inflammationHeng Li, Xianglei Zhang, Caigui Xiang, et al.Acta Pharmaceutica Sinica. B|February 7, 2022
Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasisHeng Li, Yao Zhang, Moting Liu, et al.European Journal of Medicinal Chemistry|June 13, 2021
Discovery of chiral N-2'-aryletheryl-1'-alkoxy-ethyl substituted arylisoquinolones with anti-inflammatory activity from the nucleophilic addition reactions of the thiophenols and oxazoliniumBo Li, Heng Li, Zhengdan Zhu, et al.Cell Death & Disease|April 26, 2020
Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitisHeng Li, Chunlan Feng, Chen Fan, et al.Pageof 2